MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0008263
Stenora Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹87.21 Lakh
▲ 14% YoY
Net profit · FY 2025
₹4.57 Lakh
Net margin 5.2%
EBITDA · FY 2025
₹7.23 Lakh
EBITDA margin 8.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Stenora Pharma Private Limited
Data last updated:
Stenora Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74993MH2018PTC309229. Its GSTIN is 27ABACS2938P1ZS (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arvind Kumar Sheo Kumar Shahi and Rinki Shahi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 409 4th Floor Nirmal Corporate Center Mulund (W), Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.21 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹4.57 Lakh (net margin 5.2%) and EBITDA of ₹7.23 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 153% over five years.
The company is associated with 1 brand: Stenora. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
Stenora Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0008263). For more details, the company can be reached via its website stenorapharma.com.
Company details
CIN U74993MH2018PTC309229
Registration Number 309229
Incorporation Date 10 May 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0008263
Recognitions & Rankings of Stenora Pharma
Contact details
Stenora Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is stenorapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 409 4th Floor Nirmal Corporate Center Mulund (W), Mumbai, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stenora Pharma Private Limited, buy the company report.
Comprehensive company report
Stenora Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Stenora Pharma operates one associated brand: Stenora. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and exporting of drugs in India. | stenorapharma.com |
Business activity
The main business activity of Stenora Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Stenora Pharma Private Limited, buy the company report.
Financials of Stenora Pharma Private Limited
FY 2025 filings availableStenora Pharma Private Limited reported revenue of ₹87.21 Lakh (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹87.21 Lakh ▲ 14%
Net profit · FY 2025
₹4.57 Lakh margin 5.2%
EBITDA · FY 2025
₹7.23 Lakh margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 1%
5 years · compounded
▲ 153%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 46%
5 years · compounded
▲ 223%
Revenue has grown at a compounded annual rate (CAGR) of 153% over five years, including 14% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stenora Pharma Private Limited, buy the company report.
Board of directors of Stenora Pharma Private Limited
Stenora Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Sheo Kumar Shahi Also directs: Stenora Agro & Chemicals Private Limited, Genorise Biotech Private Limited, Crescentia Biotech Private Limited and 4 more | Director | 10 May 2018 | 8 Years 5 Months | Current |
| Rinki Shahi | Director | 10 May 2018 | 8 Years 5 Months | Current |
Auditor
Stenora Pharma Private Limited is audited by DEVENDRA D SANKHALA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEVENDRA D SANKHALA & ASSOCIATES | FY 2020 | 140654W |
Shareholding
The shareholding of Stenora Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Stenora Pharma Private Limited, buy the company report.
Legal cases
Stenora Pharma Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed against the company by M/S Sai Parenterals Pvt Ltd Rep by Managing Director Vijitha Gorrepati | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by M/S Via Logistics Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed against the company by M/S Via Logistics Private Limited | Disposed |
To see the full case history of Stenora Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stenora Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stenora Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABACS2938P1ZS | Maharashtra | Active | 14 Feb 2019 |
To see the full GST registrations and return filing status of Stenora Pharma Private Limited, buy the company report.
Recent activity
Stenora Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Arvind Kumar Sheo Kumar Shahi was appointed as Director on 10 May 2018.
AGM
Stenora Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stenora Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Arvind Kumar Sheo Kumar Shahi was appointed as Director.
Appointed
Rinki Shahi was appointed as Director.
Incorporation
10 May 2018
Stenora Pharma Private Limited was registered on 10 May 2018 with Roc Mumbai I & aged 8 years 5 months as per MCA records.
Frequently asked questions
Stenora Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2018 (8+ years old) and is registered under CIN U74993MH2018PTC309229.
Stenora Pharma has 2 current directors:
- Arvind Kumar Sheo Kumar Shahi - Director
- Rinki Shahi - Director
The latest financial statements of Stenora Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Stenora Pharma is 27ABACS2938P1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Stenora Pharma is U74993MH2018PTC309229. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stenora Pharma has 3 court cases on record: 3 filed against it. 1 is pending.
Stenora Pharma was incorporated on 10 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Arvind Kumar Sheo Kumar Shahi was appointed as Director on 10 May 2018. Rinki Shahi was appointed as Director on 10 May 2018.
Yes, Stenora Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0008263).
Stenora Pharma can be reached through the website stenorapharma.com. Its registered office is in Mumbai, Maharashtra, India.